What is the most likely diagnosis and recommended treatment for a non‑pruritic, reticulated or hypopigmented macular rash confined to the abdomen and flank?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 10, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Tinea Versicolor (Pityriasis Versicolor)

The most likely diagnosis is tinea versicolor (pityriasis versicolor), a superficial fungal infection caused by Malassezia species that characteristically presents as hypopigmented, reticulated, non-pruritic macules on the trunk and should be treated with topical ketoconazole 2% cream applied once daily for two weeks. 1, 2

Clinical Diagnosis

  • Tinea versicolor characteristically presents as scaly hypopigmented or hyperpigmented macules/patches primarily located on the upper trunk, neck, and upper arms—exactly matching this patient's distribution on abdomen and flank. 2

  • The non-pruritic nature is typical, as tinea versicolor is generally asymptomatic or minimally symptomatic. 3

  • The reticulated or hypopigmented appearance is pathognomonic for the hypopigmented variant (pityriasis versicolor alba), which occurs when fungal metabolites inhibit melanin synthesis. 4

  • Diagnosis is usually made clinically based on characteristic features without requiring laboratory confirmation. 2

  • If diagnostic uncertainty exists, potassium hydroxide (KOH) preparation reveals numerous short, stubby hyphae intermixed with clusters of spores ("spaghetti and meatballs" appearance). 2

First-Line Treatment

Topical antifungal therapy is the treatment of choice due to better safety profile, fewer adverse events, fewer drug interactions, and lower cost compared to systemic treatment. 2, 5

  • Apply ketoconazole 2% cream once daily to the affected area and immediate surrounding skin for two weeks to reduce recurrence risk. 1

  • Alternative topical options include zinc pyrithione shampoo, selenium sulfide, or terbinafine cream. 5, 6

  • Clinical improvement may be seen fairly soon after treatment begins, but the full two-week course is essential to prevent recurrence. 1

When to Consider Oral Therapy

Oral antifungal therapy should be reserved for specific situations: 2, 5

  • Extensive disease covering large body surface areas
  • Frequent recurrences despite topical therapy
  • Disease refractory to adequate topical treatment
  • Patient preference when compliance with topical therapy is poor

If oral therapy is indicated, use either itraconazole or fluconazole—oral ketoconazole should no longer be prescribed due to hepatotoxicity risk, and oral terbinafine is ineffective for tinea versicolor. 5

Critical Management Pitfalls

  • The hypopigmentation may persist for weeks to months after successful fungal eradication, as repigmentation requires time for melanocyte recovery and new melanin synthesis. 4

  • Patients must understand that clearing the infection does not immediately restore normal pigmentation—this prevents premature discontinuation of therapy or unnecessary retreatment. 4

  • Recurrence rates are high (up to 60% within one year) because Malassezia species are part of normal skin flora. 2, 6

  • Long-term intermittent prophylactic therapy should be considered for patients with frequent recurrences, such as monthly application of topical antifungals or periodic oral therapy. 5, 6

Differential Considerations to Exclude

While tinea versicolor is the clear diagnosis here, briefly consider:

  • Vitiligo presents with complete depigmentation (not hypopigmentation) and lacks the fine scale characteristic of tinea versicolor. 3

  • Post-inflammatory hypopigmentation requires a history of preceding inflammatory dermatosis. 3

  • Pityriasis alba occurs primarily on the face in children and has less distinct borders. 3

  • The non-pruritic nature and trunk distribution exclude inflammatory conditions like eczema or psoriasis. 2

References

Research

Tinea versicolor: an updated review.

Drugs in context, 2022

Research

Pityriasis versicolor alba.

Journal of the European Academy of Dermatology and Venereology : JEADV, 2005

Research

Antifungal Treatment for Pityriasis Versicolor.

Journal of fungi (Basel, Switzerland), 2015

Research

Management of seborrheic dermatitis and pityriasis versicolor.

American journal of clinical dermatology, 2000

Related Questions

What is the difference between tinea versicolor and pityriasis versicolor?
What is the recommended initial treatment for tinea versicolor, including topical and oral options, and how should management be altered in pregnancy, lactation, liver disease, or children under 12?
What is the appropriate treatment for tinea versicolor of the groin with intense itching?
In a patient with tinea versicolor on fluconazole 150 mg weekly, how should mild versus severe sweating be managed, and when should fluconazole be discontinued or switched to an alternative regimen?
Are hockey players at increased risk for tinea versicolor due to heavy sweating and wearing tight, non‑breathable equipment?
How should I manage a patient taking spironolactone and losartan who has a serum potassium of 5.5 mEq/L?
Can trazodone cause tinnitus (buzzing in the ears)?
What are the differences between time‑dependent (time‑kill) and concentration‑dependent (peak‑kill) antibiotics, and how should their dosing regimens be optimized (e.g., dosing frequency, infusion methods, therapeutic drug monitoring) especially in patients with renal impairment or severe infections?
Which antibiotics are concentration‑dependent and what are the recommended dosing strategies for an adult with normal renal function?
In an adult without contraindications, how long does a loading dose of aspirin (acetylsalicylic acid, 162–325 mg) take to achieve antiplatelet effect?
For a patient with focal intestinal metaplasia at the incisura angularis, no dysplasia, second-degree family history of gastric cancer, and prior Helicobacter pylori infection (current biopsies negative), what does surveillance entail and what condition is being monitored?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.